Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 17, 2020Annals of HepatologyOpen Access

Osteopontin – A potential biomarker of advanced liver disease

View Full Paper
Ask AI
Bookmark
Share

Authors

RBRadan BrůhaCharles UniversityLVLibor Vı́tekCharles UniversityVŠV. ŠmídCzech Academy of Sciences

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Brůha et al. (2020) studied this question.

synapsesocial.com/papers/6a70187726a7f98052dc9a4ehttps://doi.org/10.1016/j.aohep.2020.01.001
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Osteopontin: Versatile modulator of liver diseases2013 · 88 citations
  2. 2Evaluation of Osteopontin and Pokémon genes expression in hepatitis C virus–associated hepatocellular carcinoma2018 · 5 citations
  3. 3Schistosome-induced cholangiocyte proliferation and osteopontin secretion correlate with fibrosis and portal hypertension in human and murine schistosomiasis mansoni2015 · 33 citations
  4. 4Osteopontin deficiency aggravates hepatic injury induced by ischemia–reperfusion in mice2014 · 48 citations